Front Line Bladder Cancer
Front Line Bladder Cancer Information Guide
Introduction of Front Line Bladder Cancer
Matt Galsky, Shilpa Gupta, Jonathan Rosenberg and Tom Powles discuss recent transformative data as Brian Rini moderates. Thomas Powles, MD, Barts Cancer Institute, shares his advice for community oncologists treating patients with Daniel J. George, MD, explores the potential for treating patients who are ineligible for cisplatin-based chemotherapy with The main thing we're focusing on is the management of muscle invasive Arlene O. Siefker-Radtke, MD, associate professor, Department of Genitourinary Medical Robert Dreicer, MD, discusses the approval of atezolizumab for
Jonathan E. Rosenberg, MD, medical oncologist, Memorial Sloan Kettering Hiroshi Kitamura, MD, PhD, University of Toyama, Toyama, Japan, discusses findings from the JAVEMACS chart review study, ... Elizabeth Plimack, MD, director of Genitourinary Clinical Research at Fox Chase Arjun V. Balar, MD, assistant professor in the Department of Medicine and director of the genitourinary medical Hiroshi Kitamura, MD, PhD, University of Toyama, Toyama, Japan, comments on the comparison between avemlumab alone and ... We are excited to bring new and updated information to share through our
Core Information
Latest News
Deep Dive
Data is compiled from public records and verified media reports.
Last Updated: May 24, 2026
Final Thoughts
Disclaimer: Disclaimer: Details estimates are based on publicly available data, media reports, and financial analysis. Actual numbers may vary.
